Hyundai and Uber team up to develop all-electric flying taxis

In the midst of technological advancements increasing at a commendable pace, Uber’s flying taxi initiative seems to be edging closer to reality – the reality of establishing flying cars in the near future. The ride-hailing giant....

VR solutions developer HumanEyes launches cloud-based suite

HumanEyes Technologies, a leading global supplier of virtual reality solutions, will present immersive and shareable VR experiences at CES 2020, which starts on 7th January and ends on 10th January in Las Vegas. The company will showcase it....

BioNTech publishes proof-of-concept data for BNT211 CAR-T cell therapy

The report will contain data of CAR-T product candidate called BNT211, an autologous CAR-T cell therapy BioNTech SE, a biotechnology firm based in Germany, recently announced a publication in Science regarding a therapeutic CAR-T approach ....

EMA approves marketing authorization application for Lumoxiti®

Innate Pharma SA, a commercial-stage oncology-focused biotech firm, has successfully attain Marketing Authorization Application (MMA) approval for Lumoxiti from the European Medicines Agency (EMA). For the record, Lumoxiti is a first-in-cla....

Isracann announces to enter into MoU for European distribution

Isracann Biosciences, Inc., an Israel-based specialty pharmaceutical company, announced that it has entered into a Memorandum of Understanding (MoU) for a distribution agreement to serve major legalized cannabis markets in Europe. The ....

BioXcel begins Phase 3 BXCL501 trial for treating SCZ & bipolar disorder

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical firm leveraging artificial intelligence approaches to advance the next wave of medicines in immuno-oncology and neuroscience, has reportedly announced the initiation of its SERE....

Starpharma initiates Phase 1 study for AZD0466 using DEP® platform

Starpharma, a world leader in dendrimer product development, reportedly announced that AstraZeneca, a renowned British-Swedish biopharmaceutical company, has initiated a phase 1 clinical study of AZD0466. The first patient in this trial has....

Spring Bank refrains from dosing patients in Inarigivir clinical trials

Clinical-stage biopharmaceutical company, Spring Bank Pharmaceuticals, Inc. has reportedly stopped patient dosing and enrollment in its Phase 2b CATALYST studies that aim at evaluating the use of inarigivir soproxil 400mg for treating chron....

Iterum declares completion of enrollment in sulopenem clinical trial

The clinical trial was aimed at the treatment of uncomplicated urinary tract infections. The enrollment is expected to garner topline results in quarter one of 2020. Ireland based Iterum Therapeutics has reportedly announced the compl....

Lineage Cell Therapeutics unveils plans to ink three new license deals

Lineage Cell Therapeutics, a California based clinical stage biotechnology company, that develops novel cellular therapies for medical needs that are not fulfilled, has reportedly announced its plans to enter into license deals with three d....